All Stories

  1. Risk Factors for Mortality Among Patients with Bloodstream Infection Caused by Candidozyma auris in Colombia
  2. Temporal Trends and Seasonality of Invasive Candidiasis During and After the COVID-19 Pandemic: An Interrupted Time Series Analysis in Colombia
  3. Bacteriemia por Comamonas testosteroni e infección polimicrobiana intrahospitalaria luego de estancia prolongada. Reporte de caso
  4. Directrices unificadas para la interpretación y manejo de las viremias de bajo nivel persistentes del VIH en Colombia. Declaración de consenso
  5. Establishing tropical medicine as a recognized medical specialty or strengthening its training within infectious diseases residency programs in Colombia: an urgent need
  6. Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus
  7. Chest X‐Ray Interpretation in the EPICO Pediatric COVID‐19 Study: Addressing Misconceptions
  8. Renaming the tropical febrile syndrome: A clinical and semantic imperative in global health
  9. Correction: Long COVID clinical evaluation, research and impact on society: a global expert consensus
  10. Mpox: Characterization and clinical outcomes of patients in Colombian healthcare institutions
  11. Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama
  12. Key success factors in clinical trial operation of the smallpox vaccine LC16m8 against mpox in Colombia
  13. Corrigendum: Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study
  14. Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study
  15. Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease
  16. Multiplex PCR Pneumonia Panel in Critically Ill Patients Did Not Modify Mortality: A Cohort Study
  17. What to Look for in Chest X‐Rays of Pediatric Patients With COVID‐19: Insights From a Colombian Cohort
  18. Uveítis infecciosa: epidemiología, etiología, rendimiento de pruebas diagnósticas y tratamiento
  19. Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit
  20. Management and efficiency in highly complex public healthcare: an analysis of financial ratios and non-parametric statistic
  21. Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings
  22. Interplay of Transcriptomic Regulation, Microbiota, and Signaling Pathways in Lung and Gut Inflammation-Induced Tumorigenesis
  23. Predictive modelling of the effectiveness of vaccines against COVID-19 in Bogotá: Methodological innovation involving different variants and computational optimisation efficiency
  24. ¿Cómo prepararnos para una futura pandemia?
  25. Global transcriptomic network analysis of the crosstalk between microbiota and cancer-related cells in the oral-gut-lung axis
  26. The Effectiveness of Generic Piperacillin/Tazobactam in Managing Gram-Negative Bacillary Bacteremia in Adult Patients at a Tertiary Care Hospital
  27. Guía de práctica clínica para el diagnóstico y tratamiento de la histoplasmosis en personas adultas que viven con el VIH – versión corta
  28. Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram-Negative Bacilli Bacteremia: A Randomized Double-Blind Clinical Study
  29. Financiación pública de los sistemas de Ciencia e Innovación en Latinoamérica: Una herramienta esencial para mejorar la prevención y la atención en salud
  30. Guía de práctica clínica para el diagnóstico y tratamiento de la criptococosis en personas adultas que viven con el VIH
  31. Differential Diagnosis in the Management of Acute Respiratory Infections through Point-of-Care Rapid Testing in a Post-Pandemic Scenario in Latin America: Special Focus on COVID-19, Influenza, and Respiratory Syncytial Virus
  32. Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review
  33. Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram‐Negative Bacilli Bacteremia: A Randomized Double‐Blind Clinical Study
  34. Challenges and opportunities in the face of Mpox in Latin America
  35. Mpox: Characterization and Clinical Outcomes of Patients in Colombian Healthcare Institutions
  36. Mpox: Characterization and Clinical Outcomes of Patients in Colombian Healthcare Institutions
  37. Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis
  38. Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
  39. SARS-CoV-2 vaccination strategies: Should the extended dosing interval strategy be implemented in future pandemics?
  40. Multinational prospective cohort study of incidence and risk factors for central line-associated bloodstream infections in ICUs of 8 Latin American countries
  41. Bacteremia by non-O1/non-O139 Vibrio cholerae: Case description and literature review
  42. Long COVID in low-income and middle-income countries: the hidden public health crisis
  43. Reasons for antiretroviral switching in Colombia: A retrospective cohort study
  44. The global challenges of the long COVID-19 in adults and children
  45. Mortality Caused by Candida auris Bloodstream Infections in Comparison with Other Candida Species, a Multicentre Retrospective Cohort
  46. Interventions to Improve Antibiotic Use in Hospitals with Different Levels of Complexity in Colombia: Findings from a Before-and-After Study and Suggestions for the Future
  47. Associated factors for mortality in a COVID-19 colombian cohort: is the third wave relevant when Mu variant was predominant epidemiologically?
  48. Clinical and epidemiological characteristics of mpox: A descriptive cases series in Colombia
  49. Viral reactivations and co-infections in COVID-19 patients: a systematic review
  50. Guía de práctica clínica colombiana para el tratamiento de infecciones bacterianas de piel y tejidos blandos superficiales en Población pediátrica
  51. Consenso de expertos para el tratamiento antimicrobiano de las infecciones causadas por bacilos gram negativos multirresistentes en pacientes adultos
  52. Multinational prospective cohort study over 24 years of the risk factors for ventilator-associated pneumonia in 187 ICUs in 12 Latin American countries: Findings of INICC
  53. The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?
  54. Fungemia in Hospitalized Adult Patients with Hematological Malignancies: Epidemiology and Risk Factors
  55. Comment on: Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed methods needs assessment in France, the United States, Mexico and India
  56. Molecular and Clinical Data of Antimicrobial Resistance in Microorganisms Producing Bacteremia in a Multicentric Cohort of Patients with Cancer in a Latin American Country
  57. Adenovirus Respiratory Infections Post Pandemic in Colombia
  58. Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care?
  59. Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
  60. Associated Factors for Mortality in a COVID-19 Colombian Cohort by Epidemic Wave: Is the Predominance of Mu Variant Relevant?
  61. Clinical and Epidemiological Characteristics of Mpox: A Descriptive Cases Series in Colombia
  62. Metformin Use Is Associated With Lower Mortality in Veterans With Diabetes Hospitalized With Pneumonia
  63. Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic
  64. The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) Database
  65. Multinational Prospective Cohort Study of Mortality Risk Factors in 198 ICUs of 12 Latin American Countries over 24 Years: The Effects of Healthcare-Associated Infections
  66. Association of medical tests use with care continuity in primary care service: evidence from the Department of Veterans Affairs
  67. Expert Review of Global Real-World Data on COVID-19 Vaccine Booster Effectiveness & Safety During the Omicron-dominant Phase of the Pandemic
  68. Further implications on the global real-world vaccine effectiveness against SARS-CoV-2
  69. Section 2. Colombian consensus for prophylaxis, treatment and prevention of invasive aspergillosis in adult and pediatric patients
  70. Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients
  71. Section 4. Colombian consensus on the diagnosis and treatment of chronic, saprophytic and/or allergic syndromes associated with Aspergillus spp. in adult and pediatric patients
  72. Section 1. Colombian consensus on the diagnosis and follow-up of invasive aspergillosis and Aspergillus disease in adult and pediatric patients
  73. Guía de práctica clínica para la Profilaxis quirúrgica antimicrobiana
  74. The environment also molds microbes in our respiratory airways that are important for our health
  75. Impact of SARS-CoV-2 vaccination in healthcare workers in a network of clinics in Latin America
  76. Cardiovascular risk factors and comorbidities in people living with HIV: A cross-sectional multicenter study from Colombia comorbidities in a Colombian PLWHIV population
  77. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
  78. An Operations Approach for Reducing Glycemic Variability: Evidence from a Primary Care Setting
  79. A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts
  80. Strengthening a Study of Diabetes Progression After Statin Use—Reply
  81. The Risk of Clostridioides difficile Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
  82. Head-to-head comparison of CLSI, EUCAST, Etest and Vitek2 results for Candida auris susceptibility testing
  83. Impact of TR34/L98H, TR46/Y121F/T289A and TR53 Alterations in Azole-Resistant Aspergillus fumigatus on Sterol Composition and Modifications after In Vitro Exposure to Itraconazole and Voriconazole
  84. Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial
  85. Associated Factors for Mortality in a COVID-19 Colombian Cohort by Epidemic Wave: Is the Predominance of Mu Variant Relevant?
  86. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistantCandida glabrata
  87. Guía de práctica clínica para el manejo de la neumonía adquirida en la comunidad
  88. Long-term consequences of the misuse of ivermectin data
  89. Association of Statin Therapy Initiation With Diabetes Progression
  90. Enhancing Regulatory Decision Making for Postmarket Drug Safety
  91. Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia
  92. Colombian HIV/AIDS registry and health risk management
  93. Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis
  94. Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19
  95. Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis
  96. Manifestaciones radiológicas de la melioidosis pulmonar. Serie de casos
  97. SECCION I. Antecedentes de infección por SARS-CoV-2/COVID-19
  98. Clinical course, biomarkers, management and outcomes of patients hospitalised due to COVID-19 in Colombia
  99. Consensus Recommendations Based on Evidence for Abdominal Sepsis in the Pediatric and Adult Population of Colombia
  100. Implications of Antibiotic Use during the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America
  101. Socioeconomic inequalities associated with mortality for COVID-19 in Colombia: a cohort nationwide study
  102. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1–5
  103. Guía de práctica clínica para la tamización de pacientes con riesgo de colonización por Enterobacterales productores de carbapenemasas y el manejo de infecciones causadas por estas bacterias
  104. Do the types and routes of proton pump inhibitor treatments affect clostridium difficile in ICU patients? A retrospective cohort study
  105. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
  106. Experience of clinical screening for COVID-19 among patients undergoing elective orthopedic surgeries: an alternative proposal
  107. Real-World Use of Generic Meropenem: Results of an Observational Study
  108. Prevalence and Significance of Potential Pharmacokinetic Drug–Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials
  109. Burden and magnitude of risk in HIV/AIDS in the Colombian health system: a real-world data approach
  110. Understanding the Potential Role of Therapeutics in Preventing Deaths Due to COVID-19: A Modelling Analysis
  111. Socioeconomic inequalities associated with mortality for COVID-19 in Colombia: A cohort nation-wide study
  112. <p>Acetylcholine Regulates Pulmonary Pathology During Viral Infection and Recovery</p>
  113. Real-World Effectiveness of Meropenem: Results of an Observational Study in 84 Colombian Patients
  114. Citoquinas pro y anti-inflamatorias en la infección por SARS-CoV-2, en población de Colombia
  115. Case Report: Gestational Melioidosis through Perinatal Transmission
  116. A One Health Perspective to Recognize Fusarium as Important in Clinical Practice
  117. Candida auris: A Latent Threat to Critically Ill Patients With Coronavirus Disease 2019
  118. A One Health Perspective to Recognize Fusarium and Neocosmospora as Important in Clinical Practice
  119. Una hoja de ruta para la Vacuna COVID 19 en Colombia, un reto posible
  120. Maintaining Continuity in Service: An Empirical Examination of Primary Care Physicians
  121. Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case‐control study
  122. Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
  123. 1596-P: Evaluating Reports of Pancreatic Malignancy and Liraglutide: A Pharmacovigilance Study of the FDA Adverse Event Reporting System
  124. Toward to establish selection criteria for rapid serological tests for COVID-19
  125. Volver a empezar: cirugía electiva durante la pandemia del SARS-CoV2. Recomendaciones desde la Asociación Colombiana de Cirugía
  126. Testing Dilemmas: Post negative, positive SARS-CoV-2 RT-PCR – is it a reinfection?
  127. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19)
  128. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
  129. Temporal Factors Associated With Opioid Prescriptions for Patients With Pain Conditions in an Urban Emergency Department
  130. Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study
  131. Evaluation of Vitamin B12 Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy
  132. Persistence of clonal azole-resistant isolates of Candida albicans from a patient with chronic mucocutaneous candidiasis in Colombia
  133. QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care
  134. Impact of a Formulation Containing Unusual Polyunsaturated Fatty Acids, Trace Elements, Polyphenols and Plant Sterols on Insulin Resistance and Associated Disturbances
  135. Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
  136. Association of atypical antipsychotics and mortality for patients hospitalised with pneumonia
  137. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module
  138. Risk factors associated with methicillin-resistant Staphylococcus aureus skin and soft tissue infections in hospitalized patients in Colombia
  139. Statin use and medically attended acute respiratory illness among influenza vaccine recipients
  140. Guía de práctica clínica para el diagnóstico y manejo de las infecciones de piel y tejidos blandos en Colombia
  141. Clinical practice guidelines: An Opportunity to provide health care with excellence and the new Colombian Guidelines for the diagnosis and management of Skin and Soft tissue infections (SSTIs)
  142. Case Series Study of Melioidosis, Colombia
  143. Risk of invasive fungal infections during hospital construction
  144. A cohort study of two intravenous treatments for iron deficiency in patients with heart failure
  145. Abstract 3368: Prevalence and significance of drug-drug interactions among patients with lung cancer
  146. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study
  147. Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia
  148. The cost of hospital care for HIV patients in Colombia: an insurer’s perspective
  149. Melioidosis en Colombia, descripción de un caso clínico y consideraciones epidemiológicas
  150. First case of Aspergillus caelatus airway colonization in a Chronic Obstructive Pulmonary Disease patient
  151. Antifungal stewardship: consensus on the diagnosis, treatment, and prevention of Candida spp. disease is a fundamental step in the road map to achieve it
  152. Colombian consensus on the diagnosis, treatment, and prevention of Candida Spp. disease in children and adults*,+
  153. Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia, South America
  154. Evaluación y manejo del riesgo cardiovascular en infección por VIH. Consenso de expertos ACIN
  155. Paracoccidioidomycosis simulating Crohn’s disease
  156. Necrotizing fasciitis caused by Apophysomyces variabilis in an immunocompetent patient
  157. Association of Statin Use with Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study
  158. Use of QTc-prolonging medications among patients with lung cancer: implications for clinical trials and standard clinical care.
  159. Impact of total body weight on acute kidney injury in patients with gram-negative bacteremia
  160. Opciones terapéuticas frente a especies de Candida resistentes a las equinocandinas
  161. Polypharmacy and patterns of prescription medication use among cancer survivors
  162. First report of sporadic cases of Candida auris in Colombia
  163. Burden of Fungal Infections in Colombia
  164. What has been researched about MDR- Candida auris ? A bibliometric analysis on the ‘new kid on the block’ in hospital-associated infections
  165. Erratum for Arias et al., “A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries”
  166. Association of Statin Therapy With Risk of Epilepsy in 2 Propensity Score–Matched Cohorts
  167. Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis
  168. Usefulness of thick blood smears in the diagnosis of disseminated histoplasmosis
  169. Practical Recommendations for Preoperative Skin Antisepsis
  170. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study
  171. Metformin Safety Warnings and Diabetes Drug Prescribing Patterns for Older Nursing Home Residents
  172. A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries
  173. Association of Statin Use With Risk of Back Disorder Diagnoses
  174. Tigeciclina en infecciones de piel y tejidos blandos complicadas.
  175. First Colombian consensus on congenital Chagas and clinical approach for women of child-bearing age diagnosed with Chagas
  176. Tigeciclina en infecciones intraabdominales complicadas
  177. Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population
  178. High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I–III Breast Cancer Patients Treated in a Safety-Net Healthcare System
  179. Impact of total body weight on 30-day mortality in patients with gram-negative bacteremia
  180. Lingual tuberculosis in an HIV/AIDS patient
  181. Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia
  182. Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia
  183. Low–health literacy flashcards & mobile video reinforcement to improve medication adherence in patients on oral diabetes, heart failure, and hypertension medications
  184. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module
  185. Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDI-TOF systems are the same: focus on the C. parapsilosis species complex
  186. Risk factors for methicillin-resistant Staphylococcus aureus bacteremia: A multicenter matched case-control study
  187. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line–associated bloodstream infection rates
  188. Consenso colombiano para la estratificación, diagnóstico, tratamiento y prevención de la infección por citomegalovirus en pacientes adultos con trasplante renal
  189. Impact of an Analgesia-Based Sedation Protocol on Mechanically Ventilated Patients in a Medical Intensive Care Unit
  190. Saksenaea erythrospora infection after medical tourism for esthetic breast augmentation surgery
  191. Virus de hepatitis B y C. Retos en su tratamiento
  192. Pérdida de seguimiento y factores asociados en pacientes inscritos en el programa de HIV/sida del Hospital Universitario San Ignacio, Colombia, 2012-2013
  193. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries
  194. Abstract C59: Initiation of adjuvant hormonal therapy among uninsured stage I-III breast cancer patients treated in a safety-net healthcare system
  195. Factores de riesgo para bacteriemia adquirida en el hospital por Pseudomonas aeruginosa resistente a carbapenémicos en un hospital colombiano
  196. Challenges with Diagnosing and Managing Sepsis in Older Adults
  197. Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
  198. Multiple Fungicide-Driven Alterations in Azole-ResistantAspergillus fumigatus, Colombia, 2015
  199. Risk Factors Associated With Methicillin-Resistant Staphylococcus aureus (MRSA) Complicated Skin and Soft Tissue Infection in Colombia
  200. Guía de práctica clínica sobre diagnóstico y tratamiento de infección de vías urinarias no complicada en mujeres adquirida en la comunidad
  201. Safety Profile of Nifurtimox and Treatment Interruption for Chronic Chagas Disease in Colombian Adults
  202. Methicillin-Resistant Staphylococcus aureus USA300 Latin American Variant in Patients Undergoing Hemodialysis and HIV Infected in a Hospital in Bogotá, Colombia
  203. Exposure to High-Risk Medications is Associated With Worse Outcomes in Older Veterans With Chronic Pain
  204. Frecuencia de colonización de staphylococcus aureus meticilino - resistente, de enterobacterias y de candida spp. en estetoscopios y teléfonos móviles en una unidad de cuidados intensivos neonatal
  205. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications
  206. Sodium-glucose co-transporter inhibition in the treatment of diabetes: Sweetening the pot
  207. State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus
  208. Association of skeletal muscle relaxers and antihistamines on mortality, hospitalizations, and emergency department visits in elderly patients: a nationwide retrospective cohort study
  209. Multicenter Study of Skin and Soft Tissue Infections Complicated in Hospitalized Patients 2009–2014 in Colombia
  210. Empiric Weight-Based Vancomycin in Intensive Care Unit Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
  211. Costo-efectividad de linezolid comparado con vancomicina en el manejo de la neumonía asociada a ventilación mecánica en Colombia
  212. Surgical site infection rates in 4 cities in Colombia: Findings of the International Nosocomial Infection Control Consortium (INICC)
  213. Azithromycin for Elderly Patients With Pneumonia—Reply
  214. Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistantStaphylococcus aureusbacteraemia
  215. International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module
  216. Gram-negative infections in pediatric and neonatal intensive care units of Latin America
  217. Efficacy of Three Different Regimens of Primaquine for the Prevention of Relapses of Plasmodium vivax Malaria in the Amazon Basin of Peru
  218. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America
  219. Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia
  220. Primer consenso colombiano sobre Chagas congénito y orientación clínica a mujeres en edad fértil con diagnóstico de Chagas
  221. Impacto económico de la resistencia a meticilina en pacientes con bacteriemia por Staphylococcus aureus en hospitales de Bogotá
  222. Diseminación de Klebsiella pneumoniae productoras de KPC-3 en hospitales de Bogotá durante un periodo de tres años
  223. 155Implementation of a national surveillance program for antimicrobial use, Colombia 2012-2013
  224. Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia
  225. Efecto del tratamiento antibiótico inicial adecuado sobre la mortalidad en pacientes en estado crítico con bacteriemia por Pseudomonas aeruginosa
  226. Molecular epidemiology and characterization of virulence genes of community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus isolates in Colombia
  227. Resistant Gram-negative infections in the outpatient setting in Latin America
  228. Surgical Site Infections, International Nosocomial Infection Control Consortium (INICC) Report, Data Summary of 30 Countries, 2005–2010
  229. The Quality of Quality Measures: HEDIS® Quality Measures for Medication Management in the Elderly and Outcomes Associated with New Exposure
  230. Emergencia de fenotipos resistentes a cefalosporinas de tercera generación en Enterobacteriaceae causantes de infección del tracto urinario de inicio comunitario en hospitales de Colombia
  231. Frequency of microorganisms isolated in patients with bacteremia in intensive care units in Colombia and their resistance profiles
  232. Predicting out of intensive care unit cardiopulmonary arrest or death using electronic medical record data
  233. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
  234. Consenso colombiano de neumonía nosocomial 2013
  235. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents
  236. Utilidad clínica de la detección antigénica de galactomanano en el diagnóstico de aspergilosis invasora en un hospital universitario de tercer nivel en Bogotá (Colombia) 2010–2012
  237. Mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia: a multicenter cohort study in Colombia
  238. Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection
  239. Effectiveness of a multidimensional approach to reduce ventilator-associated pneumonia in pediatric intensive care units of 5 developing countries: International Nosocomial Infection Control Consortium findings
  240. Findings of the International Nosocomial Infection Control Consortium (INICC), Part II: Impact of a Multidimensional Strategy to Reduce Ventilator-Associated Pneumonia in Neonatal Intensive Care Units in 10 Developing Countries
  241. Findings of the International Nosocomial Infection Control Consortium (INICC), Part I: Effectiveness of a Multidimensional Infection Control Approach on Catheter-Associated Urinary Tract Infection Rates in Pediatric Intensive Care Units of 6 Developing...
  242. Impact of a multidimensional infection control strategy on catheter-associated urinary tract infection rates in the adult intensive care units of 15 developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)
  243. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009
  244. Características demográficas, morbilidad y mortalidad de los pacientes adultos con neutropenia febril tratados con cefepima
  245. Effects of Oral Bisphosphonate Therapy on Serum Calcium in Elderly Veterans With Poor Kidney Function
  246. Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
  247. Ranolazine for the treatment of refractory angina in a veterans population
  248. Uso prudente de antimicrobianos basado en el Plan Obligatorio de Salud
  249. The emergence of multidrug-resistant Acinetobacter baumannii in Colombia: a time-series analysis, 2001-2007
  250. Diagnóstico de micosis oportunistas en pacientes con VIH/sida: un estudio de casos en Colombia
  251. Consenso de uso de antimicrobianos en pacientes críticamente enfermos con falla renal o en riesgo de padecerla
  252. Bacteriemia por Staphylococcus aureus resistente a la meticilina en la unidad de cuidados intensivos: revisión de los estudios de pronóstico
  253. Detección de hipotiroidismo en un programa de atención de VIH/SIDA en un hospital de Bogotá, Colombia
  254. Impact of International Nosocomial Infection Control Consortium (INICC) Strategy on Central Line–Associated Bloodstream Infection Rates in the Intensive Care Units of 15 Developing Countries
  255. Guías de práctica clínica para la prevención de infecciones intrahospitalarias asociadas al uso de dispositivos médicos
  256. La prevención de las infecciones asociadas a la atención en salud: un reto en el mejoramiento de la seguridad del paciente
  257. Prevention strategies for methicillin-resistant Staphylococcus aureus (MRSA) in Latin America
  258. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America
  259. Resistencia bacteriana, transmisión cruzada y control de la infección asociada a la atención en salud
  260. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
  261. Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia
  262. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
  263. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART
  264. Differences in DeterminingIn VitroTigecycline Susceptibility According to the Agar Medium Used
  265. Central line associated bloodstream infection rates in 166 intensive care units of 54 cities in 23 developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)
  266. Changes in macrophage membrane properties during early Leishmania amazonensis infection differ from those observed during established infection and are partially explained by phagocytosis
  267. Comparison between three not pharmacological strategies aimed to prevent the dissemination of the A/H1N1 influenza virus in Colombia
  268. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART
  269. Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
  270. Neumonía necrosante por Staphylococcus aureus extrahospitalario resistente a la meticilina:reporte de dos casos en Colombia
  271. Xantelasma gástrico sobre pólipo hiperplásico
  272. Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America
  273. Transmisión de enfermedades en los vuelos comerciales: del mito a la realidad
  274. Comprometidos con el conocimiento y el control de las infecciones
  275. Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population
  276. Validación de Índices Pronósticos e Infección del Sitio Quirúrgico en Hospitales de Colombia
  277. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008
  278. Identification of Secreted Proteins that Mediate Cell-Cell Interactions in an In vitro Model of the Lung Cancer Microenvironment
  279. Third-Line Agent Selection for Patients with Type 2 Diabetes Mellitus Uncontrolled with Sulfonylureas and Metformin
  280. Haga usted el diagnóstico. Primera parte
  281. Haga usted el diagnóstico. Segunda parte
  282. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis
  283. Malaria in a Liver Transplant Recipient: A Case Report
  284. Device-Associated Nosocomial Infections in 55 Intensive Care Units of 8 Developing Countries
  285. Extra Length of Stay of Nosocomial Infections in Pediatric ICUs of Colombia and Mexico. Findings of the International Nosocomial Infection Control Consortium (INICC)
  286. Resistencia Antimicrobiana en Unidades de Cuidado Intensivo de Bogotá, Colombia, 2001-2003
  287. Canales Endémicos y Marcadores de Resistencia Bacteriana, en Instituciones de Tercer nivel de Bogota, Colombia
  288. Device-Associated Infection Rate and Mortality in Intensive Care Units of 9 Colombian Hospitals: Findings of the International Nosocomial Infection Control Consortium
  289. Community-associated Methicillin-resistantStaphylococcus aureus, Colombia
  290. AIDS in the Intensive Care Unit
  291. Application of natural gamma radiometric equipment in an underground mine in Spain
  292. Comparación de dos pruebas de aglutinación (Toxolatex ® y Toxoscreen ®) en el diagnóstico de la toxoplasmosis: propuesta de inclusión en un programa de control
  293. Prevalence of Trypanosoma cruzi and Leishmania chagasi infection and risk factors in a Colombian indigenous population
  294. Lagochilascaris minor IN A PATIENT FROM THE COLOMBIAN AMAZON: A CASE REPORT
  295. Current status of onchocerciasis in Colombia.
  296. Dissemination Control of the Antimicrobial Resistance in the Intensive Care Unit